Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus goserelin for adenomyosis
ChiCTR1900024958Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of dienogest and goserelin in adenomyosis (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Visual analogue scale, Ultrasound and 1 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dienogestgoserelin
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR1900024958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024958.